Objective: To analyze patients with Multiple Sclerosis (MS) who discontinue disease modifying drugs (DMD) and experience disease activity (DA).
Background: Although several studies have investigated outcomes related to DMD discontinuation, these results remain inconclusive. Our study aims to investigate the risk of MS disease activity after drug discontinuation.